Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

被引：0
|
作者：
Sola, MC
Christensen, RD
Hutson, AD
Tarantal, AF
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Calif Reg Primate Res Ctr, Davis, CA USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
10.1203/00006450-199904020-01575
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1558
引用
收藏
页码：265A / 265A
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR ON THE INTESTINAL GROWTH OF FETAL RHESUS-MONKEYS
    READ, LC
    TARANTAL, A
    GEORGENASCIMENTO, C
    ACTA PAEDIATRICA SCANDINAVICA, 1989, : 97 - 103
  • [42] PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ABROGATES THE LETHAL THROMBOCYTOPENIA ASSOCIATED WITH CARBOPLATIN AND IRRADIATION IN MICE
    HOKOM, MM
    LACEY, D
    KINSTLER, OB
    CHOI, E
    KAUFMAN, S
    FAUST, J
    ROWAN, C
    DWYER, E
    NICHOL, JL
    GRASEL, T
    WILSON, J
    STEINBRINK, R
    HECHT, R
    WINTERS, D
    BOONE, T
    HUNT, P
    BLOOD, 1995, 86 (12) : 4486 - 4492
  • [43] In Vivo Pharmacokinetics and Pharmacodynamics of Positional Isomers of Mono-PEGylated Recombinant Human Granulocyte Colony Stimulating Factor in Rats
    Kang, Jung Seok
    Lee, Kang Choon
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (07) : 1146 - 1151
  • [44] Single injection of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) promotes hematologic recovery in irradiated mice.
    Shibuya, K
    Takahashi, K
    Tahara, E
    Kato, T
    Akahori, H
    Miyazaki, H
    BLOOD, 1996, 88 (10) : 1400 - 1400
  • [45] Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor
    Harker, LA
    Marzec, UM
    Kelly, AB
    Cheung, E
    Tomer, A
    Nichol, JL
    Hanson, SR
    Stead, RB
    BLOOD, 1997, 89 (01) : 155 - 165
  • [46] Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys
    Guo, Lifang
    Geng, Xingchao
    Chen, Yang
    Qi, Feifei
    Liu, Li
    Miao, Yufa
    Lin, Zhi
    Yu, Min
    Li, Zuogang
    Fu, Yan
    Li, Bo
    Luo, Yongzhang
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 69 (03) : 512 - 523
  • [47] Reversibility of Heat-Induced Denaturation of the Recombinant Human Megakaryocyte Growth and Development Factor
    Linda O. Narhi
    John S. Philo
    Bin Sun
    Byeong S. Chang
    Tsutomu Arakawa
    Pharmaceutical Research, 1999, 16 : 799 - 807
  • [48] Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia
    Liu, Xi-Ting
    Zhao, Yan-Xia
    Jia, Guang-Wei
    Yang, Fan
    Zhang, Chuan-Zhou
    Han, Bing
    Dai, Jian-Hua
    Han, Yue-Qin
    Tang, Bo-Hao
    Yang, Xin-Mei
    Shi, Hai-Yan
    Zhou, Yue
    Sui, Zhong-Guo
    Chen, Jian-Zhong
    van den Anker, Johannes N.
    Zhao, Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3292 - 3300
  • [49] Reversibility of heat-induced denaturation of the recombinant human megakaryocyte growth and development factor
    Narhi, LO
    Philo, JS
    Sun, B
    Chang, BS
    Arakawa, T
    PHARMACEUTICAL RESEARCH, 1999, 16 (06) : 799 - 807
  • [50] Effect of a single dose of pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet counts: Implications for platelet apheresis.
    Tomita, D
    Petrarca, M
    Paine, T
    Olson, K
    Roskos, L
    Cheung, E
    Kisicki, J
    TRANSFUSION, 1997, 37 (09) : S8 - S8
12345